123 related articles for article (PubMed ID: 2523943)
1. The role of three domains in the biological activity of human interferon-alpha.
Fish EN; Banerjee K; Stebbing N
J Interferon Res; 1989 Feb; 9(1):97-114. PubMed ID: 2523943
[TBL] [Abstract][Full Text] [Related]
2. Structure/function studies on recombinant human gamma interferon.
Fish EN; Banerjee K; Arakawa T; Stebbing N
Drug Des Deliv; 1988 Feb; 2(3):191-206. PubMed ID: 2855574
[TBL] [Abstract][Full Text] [Related]
3. The interaction of interferon-alpha and -gamma: regulation of (2-5)A synthetase activity.
Fish EN; Hannigan GE; Banerjee K; Williams BR
Virology; 1988 Jul; 165(1):87-94. PubMed ID: 2455384
[TBL] [Abstract][Full Text] [Related]
4. Specific residues within an amino-terminal domain of 35 residues of interferon alpha are responsible for recognition of the human interferon alpha cell receptor and for triggering biological effects.
Shafferman A; Velan B; Cohen S; Leitner M; Grosfeld H
J Biol Chem; 1987 May; 262(13):6227-37. PubMed ID: 2952649
[TBL] [Abstract][Full Text] [Related]
5. Interferons-alpha/beta- and -gamma-resistant Friend cell variants exhibiting receptor sites for interferons but no induction of 2-5A synthetase and 67K protein kinase.
Coccia EM; Federico M; Romeo G; Affabris E; Cofano F; Rossi GB
J Interferon Res; 1988 Feb; 8(1):113-27. PubMed ID: 2966842
[TBL] [Abstract][Full Text] [Related]
6. Growth inhibitory effects of interferon-beta but not interferon-alpha on human glioma cells: correlation of receptor binding, 2',5'-oligoadenylate synthetase and protein kinase activity.
Rosenblum MG; Yung WK; Kelleher PJ; Ruzicka F; Steck PA; Borden EC
J Interferon Res; 1990 Apr; 10(2):141-51. PubMed ID: 2140395
[TBL] [Abstract][Full Text] [Related]
7. Biological activities and receptor binding of two human recombinant interferons and their hybrids.
Meister A; Uzé G; Mogensen KE; Gresser I; Tovey MG; Grütter M; Meyer F
J Gen Virol; 1986 Aug; 67 ( Pt 8)():1633-43. PubMed ID: 3016158
[TBL] [Abstract][Full Text] [Related]
8. Alpha-interferon receptors in malignant B-cells from patients with chronic lymphocytic leukemia: relation to induction of 2'-5'-oligoadenylate synthetase and blast transformation.
Ostlund L; Grandér D; Juliusson G; Robèrt KH; Lundgren E; Einhorn S
Cancer Res; 1989 Jun; 49(12):3425-30. PubMed ID: 2524252
[TBL] [Abstract][Full Text] [Related]
9. Antibodies to chromosome 21 coded cell surface components block binding of human alpha interferon but not gamma interferon to human cells.
Shulman LM; Kamarck ME; Slate DL; Ruddle FH; Branca AW; Baglioni C; Maxwell BL; Gutterman J; Anderson P; Nagler C; Vilcek J
Virology; 1984 Sep; 137(2):422-7. PubMed ID: 6237488
[TBL] [Abstract][Full Text] [Related]
10. Action of interferon-alpha on hairy cell leukemia: expression of specific receptors and (2'-5')oligo (A) synthetase in tumor cells from sensitive and resistant patients.
Billard C; Ferbus D; Sigaux F; Castaigne S; Degos L; Flandrin G; Falcoff E
Leuk Res; 1988; 12(1):11-8. PubMed ID: 2965776
[TBL] [Abstract][Full Text] [Related]
11. Induction of 2',5'-oligoadenylate synthetase by retinoic acid in two transformed human cell lines.
Bourgeade MF; Besançon F
Cancer Res; 1984 Nov; 44(11):5355-60. PubMed ID: 6435868
[TBL] [Abstract][Full Text] [Related]
12. Variation in the binding of 125I-labeled interferon-beta ser to cellular receptors during growth of human renal and bladder carcinoma cells in vitro.
Ruzicka FJ; Schmid SM; Groveman DS; Cummings KB; Borden EC
Cancer Res; 1987 Sep; 47(17):4582-9. PubMed ID: 2957045
[TBL] [Abstract][Full Text] [Related]
13. VIP induces in HT-29 cells 2'5'oligoadenylate synthetase and antiviral state via interferon beta/alpha synthesis.
Chelbi-Alix MK; Boissard C; Sripati CE; Rosselin G; Thang MN
Peptides; 1991; 12(5):1085-93. PubMed ID: 1724797
[TBL] [Abstract][Full Text] [Related]
14. Effects of combinations of interferon-beta ser and interferon-gamma on interferon-inducible proteins and on the cell cycle.
Schiller JH; Horisberger MA; Bittner G; Carlin JM; Storer B; Byrne GI; Willson JK; Borden EC
J Biol Response Mod; 1990 Aug; 9(4):368-77. PubMed ID: 2395002
[TBL] [Abstract][Full Text] [Related]
15. High and low potency interferon-alpha subtypes induce (2'-5') oligoadenylate synthetase with similar efficiency.
Goren T; Kapitkovsky A; Kimchi A; Rubinstein M
Virology; 1983 Oct; 130(2):273-80. PubMed ID: 6316631
[TBL] [Abstract][Full Text] [Related]
16. Differential induction of 2',5'-oligoadenylate synthetase by IFN-beta ser and IFN-alpha 2 in serum-supplemented and serum-free HL-60 leukemic cell cultures.
Fraioli M; Wu JM
J Biol Regul Homeost Agents; 1989; 3(3):112-7. PubMed ID: 2624146
[TBL] [Abstract][Full Text] [Related]
17. 2',5'-oligoadenylate synthetase in interferon-alpha- and acyclovir-treated herpes simplex virus-infected cells.
Taylor JL; Witt PL; Irizarry A; Tom P; O'Brien WJ
J Interferon Cytokine Res; 1995 Jan; 15(1):27-30. PubMed ID: 7648430
[TBL] [Abstract][Full Text] [Related]
18. Synergistic effects of HuIFN-gamma on 2',5'-oligoadenylate synthetase induction by HuIFN-alpha.
Justesen J; Berg K
J Interferon Res; 1986 Aug; 6(4):445-54. PubMed ID: 3095443
[TBL] [Abstract][Full Text] [Related]
19. Basal and interferon-induced 2',5'-oligoadenylate synthetase in human monocytes, lymphocytes, and peritoneal macrophages.
Witt PL; Spear GT; Helgeson DO; Lindstrom MJ; Smalley RV; Borden EC
J Interferon Res; 1990 Aug; 10(4):393-402. PubMed ID: 2121851
[TBL] [Abstract][Full Text] [Related]
20. Different kinetics of antiviral and anticellular activities between human recombinant and natural interferon-gamma arising from different receptor-binding properties.
Gomi K; Akinaga S; Inoue A; Morimoto M; Nakamizo N
Jpn J Cancer Res; 1986 Sep; 77(9):946-55. PubMed ID: 3095289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]